about
Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-upSelective occlusion of subfoveal choroidal neovascularization in angioid streaks by using a new technique of ingrowth site treatment.Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study).Indocyanine green mediated photothrombosis for the management of predominantly classic choroidal neovascularisation caused by age related macular degeneration.Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study).Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema: one-year results of a randomized clinical trial.Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy.Polypoidal choroidal vasculopathy: angiographic characterization of the network vascular elements and a new treatment paradigm.Indocyanine green angiography findings in patients with long-standing Vogt-Koyanagi-Harada disease: a cross-sectional study.Subretinal pigment epithelial infiltrates in primary vitreoretinal lymphoma.Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study).An intravitreal biodegradable sustained release naproxen and 5-fluorouracil system for the treatment of experimental post-traumatic proliferative vitreoretinopathy.Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study.Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).Single intravitreal injection of triamcinolone combined with bevacizumab for the treatment of diffuse diabetic macular oedema refractory to grid photocoagulation.Neovascular ingrowth site photothrombosis in choroidal neovascularization associated with retinal pigment epithelial detachment.Optical coherence tomography findings in patients with late solar retinopathy.A single intraoperative sub-Tenon's capsule triamcinolone acetonide injection for the treatment of post-cataract surgery inflammation.STRATUS optical coherence tomography in unilateral colobomatous excavation of the optic disc and secondary retinoschisis.Intravitreal bevacizumab for diabetic macular edema associated with severe capillary loss: one-year results of a pilot study.Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal bevacizumab (IBeTra study).Optical coherence tomography findings in macular cavernous haemangioma.Occult chorioretinal anastomosis in age-related macular degeneration: a prospective study by optical coherence tomography.Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.Retinal nerve fibre layer thickness profile in normal eyes using third-generation optical coherence tomography.Evaluation of image artifact produced by optical coherence tomography of retinal pathology.Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial.Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up.Optical coherence tomographic imaging of sub-retinal pigment epithelium lipid.Multimodal fundus imaging in choroidal osteoma.Severe retinal thermal injury after indocyanine green-mediated photothrombosis for central serous chorioretinopathy.Comparison of acetazolamide, brimonidine, and anterior chamber paracentesis for ocular hypertension control after initial intravitreal bevacizumab injection: a randomized clinical trial.Optical coherence tomography evaluation of idiopathic macular hole treatment by gas-assisted posterior vitreous detachment.Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA Study): results of a phase 1 dose-escalation studyIntravitreal bevacizumab (Avastin) injection associated with regression of retinal neovascularization caused by sickle cell retinopathyIntravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasisNew stratusoct findings in extrapapillary excavated anomaly and secondary macular complicationsPreoperative B-scan ultrasonography of the vitreoretinal interface in phakic patients undergoing rhegmatogenous retinal detachment repair and its prognostic significanceThird-generation optical coherence tomography findings in punctate retinal toxoplasmosisAnti-inflammatory efficacy of a single posterior subtenon injection of triamcinolone acetonide versus prednisolone acetate 1% eyedrops after pars plana vitrectomy
P50
Q28295656-22174AA6-DAE6-4095-9C06-14CDE6CBAF82Q30727625-873549AE-C11B-4254-807F-DB28FD9FB4B5Q30837076-A5388B78-47B2-41E4-8597-7EBCAD905FFFQ33204823-FF219751-D19E-42E0-9047-822183DB34F1Q33265701-A356CDEE-266E-42D7-9C71-26DD780FFC46Q33377678-19922A09-F674-46D3-8D8A-2CBA5DDA3B9BQ34211317-9562F675-C301-4047-8DE2-834626E4FBF1Q36187655-1D5C1286-575F-4A97-BA84-F6AC72104278Q36346347-F0FE5452-9C4A-414D-A8BA-032C61E9C21BQ39347284-2093157A-0DAB-48B3-ABCB-3598B67C3244Q40159917-715DF39D-E9CE-4EFF-9152-FDD02A361A2DQ41866514-CEB11CAB-A84B-43E0-AACC-7E488B350E1AQ42611765-8F8EC978-14EB-4E5D-9056-912E17961BC2Q42613475-61E462E8-06C8-4DE9-9FD9-94EC8C99A301Q43244350-B9CA7771-D6F7-4A7F-BB86-E23291373769Q44367534-C2F6AE27-1941-42BC-9C64-6DB00A0F6C7AQ44926650-C223B4B7-C76A-4B63-A395-D72976E03381Q45136130-47DDFB40-FF7D-4E00-98E6-DA0540F1886FQ45231111-FEFC6D42-516A-4EC2-8989-D357BBBD6650Q46071387-87E9B183-2278-456F-8021-7F59E4699F7AQ46125936-E682D6B0-6A2F-43D0-9AAA-92ED1D7FB366Q46412278-5F24C7F1-75DC-49F4-A656-4362D0B79BB0Q46553721-3E239C2C-A975-4A98-A2FE-6EF93BF16E8DQ46600130-E4B196F1-4511-4C5F-969C-209BFECC985BQ46624971-D2B5C9FC-C9D7-4BFC-BEC1-9AAA2CCFF563Q46640266-BF79F57A-94E8-4813-B3B0-982E7E5CBBB0Q46722476-A47E4841-0AE6-4DE2-86EE-E9C4BF72493DQ46732910-6C8BDA5C-8A42-417E-B25D-08DEC98E904EQ50242788-6B9A1F40-DAF8-465C-9B07-9FDA72C1C254Q50259805-A79B1017-389A-43C7-B84A-70825364BA43Q50667244-4614B231-C4DB-4B9C-B5FF-579F5ABFC353Q51028831-BE72C821-1170-432B-AEE4-A247F570B2BDQ53515756-D8AFBBCD-D309-4272-9590-2699EA3BFE63Q57136732-FBA08556-72DE-411A-9299-FA245C4D6710Q79328017-1670DDA3-405D-43C6-B7B9-CCD154CA0DE2Q79394632-17828F9C-16D6-4CCF-A5A2-7BD81C7D6743Q79547150-7E22FC16-86E2-4CD5-B68E-C666DB17B4EBQ79822144-E4C66BDF-8A1B-41BF-A662-5A865C8B9218Q80173708-C6824226-8151-4C2B-B6CD-55E5DA528FECQ80216569-D9606292-FCD4-4A24-B7AE-5D995AC0983E
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rogério A Costa
@ast
Rogério A Costa
@en
Rogério A Costa
@es
Rogério A Costa
@nl
Rogério A Costa
@sl
type
label
Rogério A Costa
@ast
Rogério A Costa
@en
Rogério A Costa
@es
Rogério A Costa
@nl
Rogério A Costa
@sl
prefLabel
Rogério A Costa
@ast
Rogério A Costa
@en
Rogério A Costa
@es
Rogério A Costa
@nl
Rogério A Costa
@sl
P1053
E-6930-2013
P106
P21
P31
P3829
P496
0000-0002-0800-2233